Navigation Links
Arena Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Date:1/5/2012

SAN DIEGO, Jan. 5, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2012, at 4:00 p.m. Pacific Time (7:00 p.m. Eastern Time) at The Westin St. Francis in San Francisco, California. Jack Lief, Arena's President and Chief Executive Officer, is scheduled to provide a corporate overview, including with regard to the company's recent resubmission of the new drug application for lorcaserin.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena PharmaceuticalsArena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is intended for weight management.

Arena Pharmaceuticals® and Arena® are registered service marks of the company.

Forward-Looking StatementsCertain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the therapeutic indication of lorcaserin and Arena's focus, goals, strategy, research and development programs, and ability to develop compounds and commercialize drugs. For such statements, A
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Arena Submits Response to FDA Complete Response Letter for Lorcaserin
2. Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
3. Arena Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference
4. Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
5. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
6. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
7. Arena Pharmaceuticals Announces Second Quarter 2011 Financial Results
8. Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
9. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
10. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
11. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a ... today announced that it will release its unaudited financial results ... on Tuesday, May 28, 2013.  The Company will host a ... EDT (May 28, 2013 at 8:00 p.m. China Standard Time) ... on recent corporate developments. To access the conference ...
(Date:5/16/2013)... PLAINFIELD, N.J. , May 16, 2013  PTC ... registration statement on Form S-1 with the U.S. Securities ... public offering of its common stock. The number of ... the offering have not been determined. (Logo:  ... Credit Suisse are acting as joint book-running managers for ...
(Date:5/16/2013)... Inc. (NYSE: ALR ), a global leader in ... through the merger of rapid diagnostics and health management, has ... Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).  The dividend ... of Series B stock at the close of business on ... amount of all dividends accrued from April 1, 2013 through ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... , BERKELEY HEIGHTS, N.J. , June 15 Access ... president and chief executive officer (CEO). Since mid-2009, Access was under the ... served in addition to his responsibilities as chief financial officer (CFO). ... "I am humbled and ...
... June 15 Eleme Medical Inc., a ... all areas of body shaping, announced today that CEO ... recipient of a Leadership Award from non-profit group Women ... scientists and engineers to develop an entrepreneurial mindset and ...
Cached Medicine Technology:New President and Chief Executive Officer Named at Access Communications, LLC 2New President and Chief Executive Officer Named at Access Communications, LLC 3Eleme Medical's President and CEO Nancy Briefs Honored with Leadership Award from Women Entrepreneurs in Science and Technology 2
(Date:5/18/2013)... Orlando, FL (May 18, 2013) There are ... procedures commonly used to diagnose or treat gastrointestinal ... Week (DDW). , A study by New ... that more objective testing may substantially reduce the ... (GERD). Although GERD is believed to affect nearly ...
(Date:5/18/2013)... Utah (PRWEB) May 18, 2013 ... on insurance agents’ role in Marketplaces . ... to traditional employer sponsored health benefits, is the ... and health reimbursement arrangements . , ... Health and Human Services (HHS) recently released a ...
(Date:5/18/2013)... 2013 After working diligently for months and ... formally announced the integration of the fitment specs for the ... set to stun the automobile market with its extraordinary features ... is marked as the latest entry in the size ... up for the year 2013. , Aptly suiting its ...
(Date:5/18/2013)... AL (PRWEB) May 18, 2013 Although ... malignant tumors, the association between obesity and esophageal adenocarcinoma, ... for other obesity-related tumors. As reported on ... people are almost twice as likely as those of ... Although the relationship between obesity and esophageal cancer is ...
(Date:5/18/2013)... Houston, TX (PRWEB) May 18, 2013 Show ... many years of various different training systems that is all ... possible has caught the attention of http://ShowAndGoTrainingReview.com ’s ... Go Training is a unique “four phase system” designed ... the minimum amount of time spent working out in the ...
Breaking Medicine News(10 mins):Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
... grant program will fund STOP Diabetes, a project to ... is designed to reduce the risk for type 2 ... STOP Diabetes project was created by investigators at the ... alarming increase in lifestyle related metabolic diseases including type ...
... ... Others, Cooking Demos, Wine Tastings, Food Samples Highlight Event to ... Grow Clinic at Boston Medical Center, CONCORD, Mass., ... Bank of America today announced,that it will present "Tastes of the Tour" at the ...
... fitness directory for personal, trainers and fitness professionals, ... ... Internet exposure., THOUSAND OAKS, Calif., May 14 GreatTrainers.com, ... television and Internet exposure for members., GreatTrainers.com is a ...
... -- Tianyin,Pharmaceutical, Co., Inc., (OTC Bulletin Board: TYNP), ... (,TCM,) based in,Chengdu, China, today announced that Mr. ... will host a conference call to update shareholders ... conference call will take place at 9:00 a.m. ...
... an eight-month workplace initiative reported that headaches and neck and ... their use of painkillers halved, according to research published in ... that pain levels were less severe at the end of ... 169 staff in Turins registry and tax offices with 175 ...
... N.J., May 14 Milestone Scientific,Inc. (OTC Bulletin Board: MLSS), the ... showcasing and,demonstrating its award winning STA(TM) System at the upcoming DPRWorld ... Thursday, May 15 - Saturday, May 17, 2008, WHERE: ... Mandalay Bay ...
Cached Medicine News:Health News:International Diabetes Federation gives grant to metabolic syndrome research project in Australia 2Health News:Bank of America to Tee Up a Delicious Weekend at the 2008 Bank of America Championship 2Health News:Bank of America to Tee Up a Delicious Weekend at the 2008 Bank of America Championship 3Health News:GreatTrainers.com Announces Low-Cost Television and Internet Exposure for Members 2Health News:Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2008 Third Quarter Earnings Conference Call on Thursday, May 15, 2008 at 9:00 a.m. EDT 2Health News:Office initiative reduces headaches and neck and shoulder pain by more than 40 percent 2Health News:Office initiative reduces headaches and neck and shoulder pain by more than 40 percent 3Health News:Milestone Scientific to Exhibit at the DPRWorld(TM) 08 in Las Vegas, Nevada 2Health News:Milestone Scientific to Exhibit at the DPRWorld(TM) 08 in Las Vegas, Nevada 3
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Testing for Strabismus (ocular misalignment) just became easier. By simply placing the StrabismoScope over the patient's eye, the examiner is able to observe the occluded eye directly, but the patien...
The Welch Allyn 125 BIO is designed to achieve precise binocular viewing and stereopsis easier than ever before. Its observation paths can be adjusted from 48 mm to 74 mm to handle the widest and nar...
Welch Allyn quality in a convenient pocket size. The PocketScope fits into your pocket! Easy to use, lightweight, and perfect for general and specialist use. Take your PocketScope with you everywhere...
Medicine Products: